Farmacosmo S.p.A.

BIT:COSMO Stock Report

Market Cap: €17.7m

Farmacosmo Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Fabio de Concilio

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure11.6yrs
CEO ownership2.2%
Management average tenureno data
Board average tenure1.9yrs

Recent management updates

Recent updates

Analysis Article • Jan 06

Farmacosmo S.p.A.'s (BIT:COSMO) 35% Share Price Surge Not Quite Adding Up

Farmacosmo S.p.A. ( BIT:COSMO ) shares have had a really impressive month, gaining 35% after a shaky period beforehand...
Analysis Article • Jan 04

A Look At The Intrinsic Value Of Farmacosmo S.p.A. (BIT:COSMO)

Key Insights Farmacosmo's estimated fair value is €0.42 based on 2 Stage Free Cash Flow to Equity Current share price...
Analysis Article • Oct 07

Farmacosmo S.p.A.'s (BIT:COSMO) Business Is Trailing The Industry But Its Shares Aren't

It's not a stretch to say that Farmacosmo S.p.A.'s ( BIT:COSMO ) price-to-sales (or "P/S") ratio of 0.3x seems quite...
Analysis Article • Jun 28

Here's Why Farmacosmo (BIT:COSMO) Can Afford Some Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • May 23

A Look At The Intrinsic Value Of Farmacosmo S.p.A. (BIT:COSMO)

Key Insights The projected fair value for Farmacosmo is €0.63 based on 2 Stage Free Cash Flow to Equity Farmacosmo's...
Analysis Article • Dec 14

Revenues Not Telling The Story For Farmacosmo S.p.A. (BIT:COSMO) After Shares Rise 34%

Those holding Farmacosmo S.p.A. ( BIT:COSMO ) shares would be relieved that the share price has rebounded 34% in the...
Analysis Article • Oct 27

Farmacosmo S.p.A.'s (BIT:COSMO) Shares Not Telling The Full Story

There wouldn't be many who think Farmacosmo S.p.A.'s ( BIT:COSMO ) price-to-sales (or "P/S") ratio of 0.4x is worth a...
Analysis Article • Jul 17

Investors Appear Satisfied With Farmacosmo S.p.A.'s (BIT:COSMO) Prospects

There wouldn't be many who think Farmacosmo S.p.A.'s ( BIT:COSMO ) price-to-sales (or "P/S") ratio of 0.4x is worth a...

CEO

Fabio de Concilio (54 yo)

11.6yrs
Tenure

Fabio de Concilio serves as CEO & Director of Farmacosmo S. p.A. and also serves as its Chairman since October 2022.

Board Members

NamePositionTenureCompensationOwnership
Fabio de Concilio
Chairman & CEO3.6yrsno data2.23%
€ 394.0k
Pierluigi Pipolo
Member of the Board of Statutory Auditorsno datano datano data
Alessia Fulgeri
Chairman of the Board of Statutory Auditorsno datano datano data
Maurizio Altini
Independent Directorno datano datano data
Alessandro Maiello
Directorno datano datano data
Mirko De Falco
Non-Executive Director2.4yrsno datano data
Diego Rossano
Independent Non-Executive Director1.4yrsno datano data
Francesco Mele
Member of the Board of Statutory Auditor1.3yrsno datano data
1.9yrs
Average Tenure
53yo
Average Age

Experienced Board: COSMO's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/08 17:19
End of Day Share Price 2026/05/08 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Farmacosmo S.p.A. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mattia PetraccaIntegrae SPA
Filippo MazzoleniValueTrack